Michael Hochman, MD, MPH, board certified general internist at USC’s Keck School of Medicine, cofounder of Updates in Slow Medicine, and host of the Healthy Skeptic, MD podcast,…
Pharmacomechanical thrombolysis can be particularly effective in mitigating post-thrombotic syndrome (PTS) in younger patients, as demonstrated by data from the ATTRACT trial.
The US Surgeon General’s office has declared Thanksgiving to be National Family Health History Day. This national awareness initiative is meant to encourage families to discuss any illnesses…
The Cardio-Visual app for iPad and iPhone is designed to assist physicians in describing cardiovascular diseases and cardiac-related surgeries to their patients. Combining a library of high resolution…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only…
Mipsagargin (G-202), a new prodrug developed by GenSpera, has a unique mechanism of action that allows it to kill cancer cells without damaging surrounding tissues. Derived from thapsigargin,…
There are many ailments that can produce pain in the pelvic region, but one that is often overlooked or misdiagnosed is pelvic congestion syndrome (PCS). Affecting approximately 10%…
